EXPLANATORY NOTE
(This note is not part of the Regulations)
These Regulations amend the National Health Service (Pharmaceutical Services) Regulations 2005 (S.I. 2005/641) (“the principal Regulations”) and make consequential changes to other legislation.
Regulation 4 of these Regulations substitutes regulation 56 of the principal Regulations. The amendment to regulation 56 is required because of the change of the legislative basis upon which determinations relating to the remuneration of pharmaceutical services are made upon the coming into force of the National Health Service Act 2006. The substituted regulation 56 makes provisions relating to the determination of remuneration for persons providing pharmaceutical services by the determining authorities.
Regulation 2 and regulations 5 to 11 of these Regulations respectively update the principal Regulations and other National Health Service legislation to take account of the amendments to regulation 56.
A full regulatory impact assessment has not been produced for this instrument as no impact on the private or voluntary sector is foreseen.